The builder of the body's scaffolding — fibroblasts are the most common cells of connective tissue in animals, synthesizing the extracellular matrix and the collagen that holds organs together. When tissue is damaged they wake from their quieter fibrocyte state to repair it; when repair never switches off, the result is fibrosis.
Cell Type
Spindle-shaped connective tissue cell; the activated state of the fibrocyte
Lineage & Origin
Derived from primitive mesenchyme, like other connective tissue cells
Typically spindle-shaped, a fibroblast synthesizes the extracellular matrix and collagen — collagen fibers, glycosaminoglycans, reticular and elastic fibers.
They express vimentin, an intermediate filament marking mesodermal origin — not specific, since cultured epithelial cells may also express it.
Fibroblasts and fibrocytes are two states of one cell: the fibroblast activated, the fibrocyte less active — smaller, spindle-shaped, with less rough endoplasmic reticulum.
Structure & Location
Fibroblasts are morphologically heterogeneous, with diverse appearances depending on location and activity.
Transplanted fibroblasts can retain positional memory of the location and tissue context where they previously resided.
Fibroblasts from different anatomical sites express many genes coding for immune mediators and proteins — site by site, the same cell type is not the same cell.
Development & Origin
Like other connective tissue cells, fibroblasts derive from primitive mesenchyme. Tissue damage works the switch: it stimulates fibrocytes and induces the production of fibroblasts.
Physiological Role
The standing job is synthesis of the extracellular matrix and its collagen framework.
Fibroblasts play a critical role in wound healing, where extracellular matrix-producing myofibroblasts — the differentiated, recruited end-state — rebuild damaged tissue.
Interactions
Fibrosis is not a solo act: innate and adaptive immune responses regulate the differentiation, recruitment, proliferation and activation of myofibroblasts.
Cell-intrinsic changes in structural cells can perpetuate the fibrotic response, keeping matrix production going long after the original injury.
Clinical Relevance
Fibrosis — the accumulation of excess extracellular matrix, or scarring — is a pathological feature of most chronic inflammatory diseases.
It affects nearly every tissue in the body; if highly progressive, it leads to organ malfunction and death.
The same mechanisms that make fibroblasts heal wounds make them fibrosis effectors, hence their targeting as potential therapies.